"False"
Skip to content
printicon
Main menu hidden.

Daniel Öhlund

M.D, Ph.D., Assistant Professor and Consultant Oncologist

Wallenberg Molecular Medicine Fellow

Wallenberg Clinical Fellow

Contact

Works at

Affiliation
Assistant professor, consultant (attending) physician at Department of Diagnostics and Intervention Section: Oncology
Affiliation
The Lancet Gastroenterology & Hepatology, Elsevier 2024, Vol. 9, (3) : 205-217
Labori, Knut Jørgen; Bratlie, Svein Olav; Andersson, Bodil; et al.
Nucleic Acids Research, Oxford University Press 2023, Vol. 51, (12) : 6264-6285
Deiana, Marco; Andrés Castán, José María; Josse, Pierre; et al.
Frontiers in Genetics, Frontiers Media S.A. 2023, Vol. 14
Gonzalez-Castrillon, Luz Maria; Wurmser, Maud; Öhlund, Daniel; et al.
Cancer immunology research, American Association for Cancer Research 2023, Vol. 11, (1) : 72-92
Lidström, Tommy; Cumming, Joshua; Gaur, Rahul; et al.
Frontiers in Bioengineering and Biotechnology, Frontiers Media S.A. 2023, Vol. 11
Mason, James E.; Öhlund, Daniel
Clinical Cancer Research, American Association for Cancer Research (AACR) 2023, Vol. 29, (6) : 1137-1154
Erice, Oihane; Narayanan, Shruthi; Feliu, Iker; et al.
European Journal of Medicinal Chemistry, Elsevier 2023, Vol. 248
Bhuma, Naresh; Chand, Karam; Andréasson, Måns; et al.
International Journal of Molecular Sciences, MDPI 2022, Vol. 23, (21)
Mason, James E.; Lundberg, Erik; Jonsson, Pär; et al.
Molecular Oncology
Flodbring Larsson, Per; Karlsson, Richard; Sarwar, Martuza; et al.
Cancers, MDPI 2021, Vol. 13, (21)
Borgmästars, Emmy; Lundberg, Erik; Öhlund, Daniel; et al.
Frontiers in Cell and Developmental Biology, Frontiers Media S.A. 2021, Vol. 9
Maneshi, Parniyan; Mason, James; Dongre, Mitesh; et al.
Cancer Research, The American Association for Cancer Research 2020, Vol. 80, (7) : 1461-1474
Tian, Chenxi; Öhlund, Daniel; Rickelt, Steffen; et al.
Cancers, MDPI 2020, Vol. 12, (4)
Li, Xingru; Larsson, Pär; Ljuslinder, Ingrid; et al.
Journal of the American Chemical Society, Vol. 142, (6) : 2876-2888
Jamroskovic, Jan; Doimo, Mara; Chand, Karam; et al.
Cancers, MDPI 2020, Vol. 12, (11)
Khomiak, Andrii; Brunner, Marius; Kordes, Maximilian; et al.
International Journal of Cancer, Wiley-Blackwell 2019, Vol. 144, (8) : 1877-1887
Honda, Kazufumi; Katzke, Verena A.; Hüsing, Anika; et al.
Clinical Cancer Research, American Association for Cancer Research Inc. 2019, Vol. 25, (22) : 6742-6755
Ponz-Sarvise, Mariano; Corbo, Vincenzo; Tiriac, Hervé; et al.
Journal of Pathology, John Wiley & Sons 2019, Vol. 5, (2) : 130-141
Franklin, Oskar; Billing, Ola; Öhlund, Daniel; et al.
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences 2019, Vol. 116, (39) : 19609-19618
Tian, Chenxi; Clauser, Karl R.; Öhlund, Daniel; et al.
Gut, BMJ Publishing Group Ltd 2019, Vol. 68, (1) : 159-171
Neesse, Albrecht; Bauer, Christian Alexander; Öhlund, Daniel; et al.
Annals of Surgery, Vol. 267, (4) : 775-781
Franklin, Oskar; Jonsson, Pär; Billing, Ola; et al.
Journal of Pathology, John Wiley & Sons 2018, Vol. 246, (3) : 311-322
Morin, Eric; Sjöberg, Elin; Tjomsland, Vegard; et al.
Journal of Experimental Medicine, Vol. 214, (3) : 579-596
Öhlund, Daniel
Cell, Vol. 166, (4) : 936-976
Chio, Iok In Christine; Jafarnejad, Seyed Mehdi; Ponz-Sarvise, Mariano; et al.
Cancer Biomarkers, IOS Press 2015, Vol. 15, (1) : 1-10
Franklin, Oskar; Öhlund, Daniel; Lundin, Christina; et al.
Cell, Cell press 2015, Vol. 160, (1-2) : 324-338
Boj, Sylvia F; Hwang, Chang-Il; Baker, Lindsey A; et al.
Journal of Experimental Medicine, Vol. 211, (8) : 1503-1523
Öhlund, Daniel; Elyada, Ela; Tuveson, David
BMC Cancer, Vol. 13
Öhlund, Daniel; Franklin, Oskar; Lundberg, Erik; et al.
British Journal of Cancer, Vol. 101, (1) : 91-97
Öhlund, Daniel; Lundin, Christina; Ardnor, Bjarne; et al.
International Journal of Cancer, Vol. 122, (12) : 2805-2810
Öhlund, Daniel; Ardnor, Bjarne; Öman, Mikael; et al.

Research groups

Head of research
Daniel Öhlund Lab
A challenge to find the solution to pancreatic cancer

Pancreatic cancer can resist most existing treatments and the five-year survival rate is low.